ClinicalTrials.gov · Registerergebnisse / Registry results · 04/2019 · Randomized study

Dapagliflozin plus endurance training in inactive, overweight adults

Randomized, placebo-controlled, triple-blind phase 2 study with 37 inactive adults aged 18 to 50 with BMI 25 to 45: twelve weeks of supervised endurance training four times a week plus dapagliflozin or placebo. Outcomes: VO2max, respiratory exchange ratio, citrate synthase, insulin sensitivity, fat-free mass.

Topics: Endurance training

Original registry record: ClinicalTrials.gov NCT02371187

The full dossier with results, original numbers, charts and an interpretation for coaching practice is included with Lab. Unlock Lab